Abstract
Stem cells have essential applications in in vitro tissue engineering or regenerative medicine. However, there is still a need to understand more deeply the mechanisms of stem cell differentiation and to optimize the methods to control stem cell function. In this study, we first investigated the activity of DNA methyltransferases (DNMTs) during chondrogenic differentiation of human bone marrow-derived mesenchymal stem/progenitor cells (hBMSCs) and found that DNMT3A and DNMT3B were markedly upregulated during hBMSC chondrogenic differentiation. In an attempt to understand the effect of DNMT3A and DNMT3B on the chondrogenic differentiation of hBMSCs, we transiently transfected the cells with expression vectors for the two enzymes. Interestingly, DNMT3A overexpression strongly enhanced the chondrogenesis of hBMSCs, by increasing the gene expression of the mature chondrocyte marker, collagen type II, more than 200-fold. Analysis of the methylation condition in the cells revealed that DNMT3A and DNMT3B methylated the promoter sequence of early stem cell markers, NANOG and POU5F1(OCT-4). Conversely, the suppression of chondrogenic differentiation and the increase in stem cell markers of hBMSCs were obtained by chemical stimulation with the demethylating agent, 5-azacitidine. Loss-of-function assays with siRNAs targeting DNMT3A also significantly suppressed the chondrogenic differentiation of hBMSCs. Together, these results not only show the critical roles of DNMTs in regulating the chondrogenic differentiation of hBMSCs, but also suggest that manipulation of DNMT activity can be important tools to enhance the differentiation of hBMSCs towards chondrogenesis for potential application in cartilage tissue engineering or cartilage regeneration.
References
1.
Bachman
KE
, Rountree
MR
, Baylin
SB
. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin
. J Biol Chem
. 2001
Aug
;276
(34
):32282
–7
.
[PubMed]
0021-92582.
Barter
MJ
, Bui
C
, Young
DA
. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs
. Osteoarthritis Cartilage
. 2012
May
;20
(5
):339
–49
.
[PubMed]
1063-45843.
Berdasco
M
, Esteller
M
. DNA methylation in stem cell renewal and multipotency
. Stem Cell Res Ther
. 2011
Oct
;2
(5
):42
.
[PubMed]
1757-65124.
Bird
AP
. CpG-rich islands and the function of DNA methylation
. Nature
. 1986
May
;321
(6067
):209
–13
.
[PubMed]
0028-08365.
Challen
GA
, Sun
D
, Jeong
M
, Luo
M
, Jelinek
J
, Berg
JS
, et al. Dnmt3a is essential for hematopoietic stem cell differentiation
. Nat Genet
. 2011
Dec
;44
(1
):23
–31
.
[PubMed]
1061-40366.
Chandrakanthan
V
, Yeola
A
, Kwan
JC
, Oliver
RA
, Qiao
Q
, Kang
YC
, et al. PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells
. Proc Natl Acad Sci USA
. 2016
Apr
;113
(16
):E2306
–15
.
[PubMed]
0027-84247.
Denis
H
, Ndlovu
MN
, Fuks
F
. Regulation of mammalian DNA methyltransferases: a route to new mechanisms
. EMBO Rep
. 2011
Jul
;12
(7
):647
–56
.
[PubMed]
1469-221X8.
Ezura
Y
, Sekiya
I
, Koga
H
, Muneta
T
, Noda
M
. Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells
. Arthritis Rheum
. 2009
May
;60
(5
):1416
–26
.
[PubMed]
0004-35919.
Feng
P
, Chen
W
, Lin
H
. Prediction of CpG island methylation status by integrating DNA physicochemical properties
. Genomics
. 2014
Oct
;104
(4
):229
–33
.
[PubMed]
0888-754310.
Fernández
MP
, Young
MF
, Sobel
ME
. Methylation of type II and type I collagen genes in differentiated and dedifferentiated chondrocytes
. J Biol Chem
. 1985
Feb
;260
(4
):2374
–8
.
[PubMed]
0021-925811.
Furumatsu
T
, Tsuda
M
, Taniguchi
N
, Tajima
Y
, Asahara
H
. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment
. J Biol Chem
. 2005
Mar
;280
(9
):8343
–50
.
[PubMed]
0021-925812.
Goll
MG
, Bestor
TH
. Eukaryotic cytosine methyltransferases
. Annu Rev Biochem
. 2005
;74
(1
):481
–514
.
[PubMed]
0066-415413.
Hara
ES
, Ono
M
, Kubota
S
, Sonoyama
W
, Oida
Y
, Hattori
T
, et al. Novel chondrogenic and chondroprotective effects of the natural compound harmine
. Biochimie
. 2013
Feb
;95
(2
):374
–81
.
[PubMed]
0300-908414.
Hara
ES
, Ono
M
, Pham
HT
, Sonoyama
W
, Kubota
S
, Takigawa
M
, et al. Fluocinolone Acetonide Is a Potent Synergistic Factor of TGF-β3-Associated Chondrogenesis of Bone Marrow-Derived Mesenchymal Stem Cells for Articular Surface Regeneration
. J Bone Miner Res
. 2015
a Sep
;30
(9
):1585
–96
.
[PubMed]
0884-043115.
Hara
ES
, Ono
M
, Yoshioka
Y
, Ueda
J
, Hazehara
Y
, Pham
HT
, et al. Antagonistic Effects of Insulin and TGF-β3 during Chondrogenic Differentiation of Human BMSCs under a Minimal Amount of Factors
. Cells Tissues Organs
. 2016
b;201
(2
):88
–96
.
[PubMed]
1422-640516.
Herlofsen
SR
, Bryne
JC
, Høiby
T
, Wang
L
, Issner
R
, Zhang
X
, et al. Genome-wide map of quantified epigenetic changes during in vitro chondrogenic differentiation of primary human mesenchymal stem cells
. BMC Genomics
. 2013
Feb
;14
(1
):105
.
[PubMed]
1471-216417.
Holland
TA
, Tabata
Y
, Mikos
AG
. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering
. J Control Release
. 2005
Jan
;101
(1-3
):111
–25
.
[PubMed]
0168-365918.
Jaenisch
R
, Young
R
. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming
. Cell
. 2008
Feb
;132
(4
):567
–82
.
[PubMed]
0092-867419.
Jair
KW
, Bachman
KE
, Suzuki
H
, Ting
AH
, Rhee
I
, Yen
RW
, et al. De novo CpG island methylation in human cancer cells
. Cancer Res
. 2006
Jan
;66
(2
):682
–92
.
[PubMed]
0008-547220.
Jia
Y
, Li
P
, Fang
L
, Zhu
H
, Xu
L
, Cheng
H
, et al. Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer
. Cell Discov
. 2016
Apr
;2
(1
):16007
.
[PubMed]
2056-596821.
Jin
EJ
, Park
KS
, Bang
OS
, Kang
SS
. Akt signaling regulates actin organization via modulation of MMP-2 activity during chondrogenesis of chick wing limb bud mesenchymal cells
. J Cell Biochem
. 2007
Sep
;102
(1
):252
–61
.
[PubMed]
0730-231222.
Johnson
K
, Zhu
S
, Tremblay
MS
, Payette
JN
, Wang
J
, Bouchez
LC
, et al. A stem cell-based approach to cartilage repair
. Science
. 2012
May
;336
(6082
):717
–21
.
[PubMed]
0036-807523.
Kim
KI
, Park
YS
, Im
GI
. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage
. J Bone Miner Res
. 2013
May
;28
(5
):1050
–60
.
[PubMed]
0884-043124.
Kita
K
, Kimura
T
, Nakamura
N
, Yoshikawa
H
, Nakano
T
. PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation
. Genes Cells
. 2008
Aug
;13
(8
):839
–50
.
[PubMed]
1356-959725.
Li
E
, Bestor
TH
, Jaenisch
R
. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
. Cell
. 1992
Jun
;69
(6
):915
–26
.
[PubMed]
0092-867426.
Li
JY
, Pu
MT
, Hirasawa
R
, Li
BZ
, Huang
YN
, Zeng
R
, et al. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog
. Mol Cell Biol
. 2007
Dec
;27
(24
):8748
–59
.
[PubMed]
0270-730627.
Lin
H
, Sohn
J
, Shen
H
, Langhans
MT
, Tuan
RS
. Bone marrow mesenchymal stem cells: aging and tissue engineering applications to enhance bone healing
. Biomaterials
. 2018
.
[PubMed]
0142-961228.
Pérez-Campo
FM
, Riancho
JA
. Epigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation
. Curr Genomics
. 2015
Dec
;16
(6
):368
–83
.
[PubMed]
1389-202929.
Pöschl
E
, Fidler
A
, Schmidt
B
, Kallipolitou
A
, Schmid
E
, Aigner
T
. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage
. Ann Rheum Dis
. 2005
Mar
;64
(3
):477
–80
.
[PubMed]
0003-496730.
Shimizu
H
, Yokoyama
S
, Asahara
H
. Growth and differentiation of the developing limb bud from the perspective of chondrogenesis
. Dev Growth Differ
. 2007
Aug
;49
(6
):449
–54
.
[PubMed]
0012-159231.
Tan
AR
, Hung
CT
. Concise Review: Mesenchymal Stem Cells for Functional Cartilage Tissue Engineering: Taking Cues from Chondrocyte-Based Constructs
. Stem Cells Transl Med
. 2017
Apr
;6
(4
):1295
–303
.
[PubMed]
2157-656432.
Tewary
M
, Shakiba
N
, Zandstra
PW
. Stem cell bioengineering: building from stem cell biology
. Nat Rev Genet
. 2018
Oct
;19
(10
):595
–614
.
[PubMed]
1471-005633.
Tsuji-Takayama
K
, Inoue
T
, Ijiri
Y
, Otani
T
, Motoda
R
, Nakamura
S
, et al. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells
. Biochem Biophys Res Commun
. 2004
Oct
;323
(1
):86
–90
.
[PubMed]
0006-291X34.
Zhang
Y
, Pizzute
T
, Li
J
, He
F
, Pei
M
. sb203580 preconditioning recharges matrix-expanded human adult stem cells for chondrogenesis in an inflammatory environment - A feasible approach for autologous stem cell based osteoarthritic cartilage repair
. Biomaterials
. 2015
Sep
;64
:88
–97
.
[PubMed]
0142-9612© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
